Skip to main content

Kingfa Science & Technology (India) Ltd

NSE: KINGFA BSE: 524019

Kingfa Science & Technology (India) Limited, a subsidiary company of M/s Kingfa Science & Technology Co. Ltd China, is engaged in the business of manufacturing and supply of high-quality modified plastic compounds for automotive and consumer products and personal protective equipments like masks and gloves. [1]

5,200
52W: ₹3006 — ₹5476
PE 41.9 · Book ₹955 · +445% vs book
Market Cap₹7,047 Cr
Stock P/E41.9Price to Earnings
ROCE30.6%Return on Capital
ROE23.2%Return on Equity
Div. Yield0%Face Value ₹10

Strengths

  • +Company has reduced debt.
  • +Company is almost debt free.
  • +Company has delivered good profit growth of 44.1% CAGR over last 5 years
  • +Company's median sales growth is 25.6% of last 10 years

Weaknesses

  • Promoter holding has decreased over last 3 years: -7.97%

Shareholding Pattern

Promoters67.02%
FIIs7.76%
DIIs8.85%
Public16.36%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters74.99%74.99%74.99%74.99%74.99%67.02%8.067.02%67.02%
FIIs6.34%6.35%0.06.35%6.35%6.34%0.07.78%1.47.74%0.07.76%0.0
DIIs0%0.04%0.00%0.00.17%0.20.15%0.08.75%8.68.75%8.85%0.1
Public18.67%18.61%0.118.65%0.018.47%0.218.51%0.016.45%2.116.5%0.116.36%0.1

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales351394404416418440470462466489
Expenses306356354359362389409404405428
Operating Profit45385157565160586162
OPM %13%10%13%14%13%12%13%13%13%13%
Net Profit30243439373542404145
EPS ₹24.4420.0927.732.2630.7728.634.632.8630.3633.33

AI Insights

Revenue Trend

TTM revenue at ₹1,887Cr, up 8.1% YoY. OPM at 13%.

Debt Position

Borrowings at ₹19Cr. Debt-to-equity ratio: 0.01x. Healthy balance sheet.

Capex Cycle

CWIP at ₹45Cr (16% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 8.85% (+8.85pp change). FIIs: 7.76% (+1.42pp change). Promoters hold 67.02%.

Margin & Efficiency

ROCE improving from -9% (Mar 2014) to 31% (Mar 2025). Working capital days: 85.

Valuation

PE 41.9x with 30.6% ROCE. Price is 445% above book value of ₹955. Dividend yield: 0%.

Recent Announcements